Mgr. Pavlína Janovská, Ph.D.
Researcher III, Section of Animal Physiology and Immunology
office: bldg. D36/107
Kamenice 753/5
625 00 Brno
phone: | +420 549 49 6811 |
---|---|
e‑mail: |
Total number of publications: 57
2017
-
Casein kinase 1 delta/epsilon inhibition blocks CLL chemotaxis and delays leukemia onset in the Eµ-TCL1 mouse model of chronic lymphocytic leukemia.
Year: 2017, type: Conference abstract
-
Kompletní analýza vlastností nových inhibitorů kasein kinázy 1 pro léčbu chronické lymfocytární leukémie
Year: 2017, type:
-
Microenvironmental interactions between endothelial and lymphoma cells: a role for the canonical WNT pathway in Hodgkin lymphoma
Leukemia, year: 2017, volume: 31, edition: 2, DOI
-
Promoter methylation of ROR ligand WNTA associates with its expression in chronic lymphocytic leukemia
Year: 2017, type: Conference abstract
-
WNT signaling pathways in chronic lymphocytic leukemia and B cell lymphomas
BRITISH JOURNAL OF PHARMACOLOGY, year: 2017, volume: 174, edition: 24, DOI
-
WNT5A: a motility-promoting factor in Hodgkin lymphoma
Oncogene, year: 2017, volume: 36, edition: 1, DOI
2016
-
Autocrine Signaling by Wnt-5a Deregulates Chemotaxis of Leukemic Cells and Predicts Clinical Outcome in Chronic Lymphocytic Leukemia.
Clinical cancer research, year: 2016, volume: 22, edition: 2, DOI
-
Decreased expression of WNT3, a canonical Wnt pathway ligand is frequent in chronic lymphocytic leukemia progression and identifies patients with short treatment-free survival in mutated IGHV
Year: 2016, type: Conference abstract
-
Decreased WNT3 expression in chronic lymphocytic leukaemia is a hallmark of disease progression and identifies patients with worse prognosis in the subgroup with mutated IGHV
British journal of haematology, year: 2016, volume: 175, edition: 5, DOI
-
Chk1 inhibition significantly potentiates activity of nucleoside analogs in TP53-mutated B-lymphoid cells
Oncotarget, year: 2016, volume: 7, edition: 38, DOI